Congressional Stock Trades & Disclosures
Andrew R. Garbarino is a U.S. Representative, a Republican representing NY. As of August 2025, Bullish Whales has tracked 12 disclosed stock trades across 7 companies, representing $96.01K in disclosed transaction value, each filed publicly under the STOCK Act.
About Garbarino's congressional trading
Garbarino's disclosed activity shows a sell-leaning pattern, with 5 purchases and 7 sales (a buy-to-sell ratio of 0.71). Garbarino has traded ORMP, OSW, and TELL most frequently among disclosed positions.
Garbarino's most recent disclosed trade was a sale of The Gap, Inc. (GAP) from August 2025. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Estimated trading profits
No priced buy disclosures in this window.
No priced buy disclosures in this window.
Based on 5 of 5 disclosed buys with pricing coverage.
Apr 23, 2021 to Jun 12, 2026
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 GAPThe Gap, Inc. | Sell | $1,001 - $15,000 | 21 AUG 2025 | $20.76 | +5.45% |
 ORMPOramed Pharmaceuticals Inc | Sell | $1,001 - $15,000 | 14 JAN 2022 | $10.30 | -62.43% |
 TELLTELL | Buy | $1,001 - $15,000 | 14 JAN 2022 | $18.40 | — |
 OSWOneSpaWorld Holdings Ltd | Sell | $1,001 - $15,000 | 01 OCT 2021 | $10.17 | +153.47% |
| ORMPOramed Pharmaceuticals Inc | Sell | $1,001 - $15,000 | 01 OCT 2021 | $19.51 | -80.17% |
 GPSGPS | Buy | $1,001 - $15,000 | 01 OCT 2021 | N/A | — |
| TELLTELL | Buy | $1,001 - $15,000 | 01 OCT 2021 | $16.36 | — |
| OSWOneSpaWorld Holdings Ltd | Buy | $1,001 - $15,000 | 23 APR 2021 | $10.07 | +156.19% |
 GSSGSS | Sell | $1,001 - $15,000 | 23 APR 2021 | $0.12 | — |
 BACBank of America Corp | Sell | $1,001 - $15,000 | 23 APR 2021 | $34.70 | +61.45% |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Andrew R. Garbarino congressional trading FAQ
Can Andrew R. Garbarino legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Bullish Whales compiles Andrew R. Garbarino's disclosures so the public can review them.
Where does Bullish Whales get Andrew R. Garbarino's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Andrew R. Garbarino's stock trades?
Bullish Whales tracks every stock trade Andrew R. Garbarino discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Andrew R. Garbarino disclosed?
Bullish Whales has tracked 12 disclosed trades by Andrew R. Garbarino across 7 companies.
Which stocks does Andrew R. Garbarino trade most?
Andrew R. Garbarino's most frequently disclosed positions include ORMP, OSW, TELL, BAC, and GAP. The full list of companies and individual filings is shown on this page.
What was Andrew R. Garbarino's most recent stock trade?
Andrew R. Garbarino most recently sold The Gap, Inc. (GAP) in August 2025, according to public STOCK Act filings tracked by Bullish Whales.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.